Date:
February 10, 2026
Category:
SARS-CoV-2, influenza A+B, RSV and adenovirus antigen test (swab)
The SARS-CoV-2, Influenza A+B, RSV, Adenovirus Antigen Detection Cartridge (nasopharyngeal) is a rapid immunochromatographic test for the simultaneous detection of SARS-CoV-2, Influenza A and B viruses, Respiratory Syncytial Virus (RSV) and Adenovirus. It aims to rapidly diagnose various respiratory viral infections in patients with respiratory symptoms such as fever, cough, sore throat and nasal congestion.
Contact our sales team for availability and delivery time
What is this test?
The combined nasopharyngeal swab rapid test detects SARS-CoV-2 (COVID-19), influenza A and B, RSV, and adenovirus antigens. A single sample allows for the rapid differentiation of the most common viral respiratory pathogens in pediatrics, emergency departments, and primary care.
Technical information
- Method
- Lateral flow chromatographic immunoassay
- Result in
- 15 min
- Storage temperature
- 2–30 °C
- Shelf life
- 24 months
- Sensitivity
- 96.4 %
- Specificity
- 99 %
- Accuracy
- 98.2 %
- Equipment
- Not required – visual reading
- Compliance
- CE-marked in vitro diagnostic device
Variants and order codes
| Code | Specimen | Format | Pack size |
|---|---|---|---|
| AF-68WE3H | Swab | Cassette | 20 tests |
Accuracy, sensitivity and specificity
SARS-CoV-2: sensitivity 97.12 %; specificity 100%; precision 98.39%.
Influenza A: Sensitivity 96.60 %; specificity 100%; accuracy 99.30%.
Influenza B: sensitivity 97.22 %; specificity 100%; precision 98.83 %.
RSV: sensitivity 97.78 %; specificity 100%; precision 99.31 %.
ADV: sensitivity 100 %; specificity 99.13%; precision 99.34 %.